These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82. Treatment outcomes of children with Hodgkin lymphoma between 2000 and 2010: First report by the South African Children's Cancer Study Group. Geel JA; Chirwa TC; Rowe B; Eyal KC; Omar F; Stones DK; Goga Y; Stefan DC; van Zyl A; Van Emmenes B; Wedi O; Vaithilingum M; Hendricks MG; Pediatr Blood Cancer; 2017 Oct; 64(10):. PubMed ID: 28383768 [TBL] [Abstract][Full Text] [Related]
83. Consolidative radiation therapy for stage III Hodgkin lymphoma in patients who achieve complete response after ABVD chemotherapy. Phan J; Mazloom A; Abboud M; Salehpour M; Reed V; Zreik T; Shihadeh F; Fisher C; Wogan C; Dabaja B Am J Clin Oncol; 2011 Oct; 34(5):499-505. PubMed ID: 21537149 [TBL] [Abstract][Full Text] [Related]
85. Salvage radiotherapy in patients with relapsed and refractory Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Lymphoma Study Group. Josting A; Nogová L; Franklin J; Glossmann JP; Eich HT; Sieber M; Schober T; Boettcher HD; Schulz U; Müller RP; Diehl V; Engert A J Clin Oncol; 2005 Mar; 23(7):1522-9. PubMed ID: 15632410 [TBL] [Abstract][Full Text] [Related]
86. Phase II study of ABV (doxorubicin with increased dose, bleomycin and vinblastine) therapy in newly diagnosed advanced-stage Hodgkin lymphoma: Japan Clinical Oncology Group study (JCOG9705). Ogura M; Itoh K; Ishizawa K; Kobayashi Y; Tobinai K; Kinoshita T; Hirano M; Ueda R; Shibata T; Nakamura S; Tsukasaki K; Hotta T; Shimoyama M; Morishima Y; Leuk Lymphoma; 2013 Jan; 54(1):46-52. PubMed ID: 22712838 [TBL] [Abstract][Full Text] [Related]
87. Treatment of Early-Stage Unfavorable Hodgkin Lymphoma: Efficacy and Toxicity of 4 Versus 6 Cycles of ABVD Chemotherapy With Radiation. Gunther JR; Fanale MA; Reddy JP; Akhtari M; Smith GL; Pinnix CC; Milgrom SA; Yehia ZA; Allen PK; Osborne EM; Mawlawi O; Dabaja BS Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):110-8. PubMed ID: 27325479 [TBL] [Abstract][Full Text] [Related]
88. POG 8625: a randomized trial comparing chemotherapy with chemoradiotherapy for children and adolescents with Stages I, IIA, IIIA1 Hodgkin Disease: a report from the Children's Oncology Group. Kung FH; Schwartz CL; Ferree CR; London WB; Ternberg JL; Behm FG; Wharam MD; Falletta JM; de Alarcon P; Chauvenet AR; J Pediatr Hematol Oncol; 2006 Jun; 28(6):362-8. PubMed ID: 16794504 [TBL] [Abstract][Full Text] [Related]
89. A Contribution to solve the problem of the need for consolidative radiotherapy after intensive chemotherapy in advanced stages of Hodgkin's lymphoma--analysis of a quality control program initiated by the radiotherapy reference center of the German Hodgkin Study Group (GHSG). Eich HT; Gossmann A; Engert A; Kriz J; Bredenfeld H; Hansemann K; Skripnitchenko R; Brillant C; Pfistner B; Staar S; Diehl V; Müller RP; Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1187-92. PubMed ID: 17703895 [TBL] [Abstract][Full Text] [Related]
90. Rituximab combined with MACOP-B or VACOP-B and radiation therapy in primary mediastinal large B-cell lymphoma: a retrospective study. Zinzani PL; Stefoni V; Finolezzi E; Brusamolino E; Cabras MG; Chiappella A; Salvi F; Rossi A; Broccoli A; Martelli M Clin Lymphoma Myeloma; 2009 Oct; 9(5):381-5. PubMed ID: 19858058 [TBL] [Abstract][Full Text] [Related]
91. Long-term follow-up analysis of HD9601 trial comparing ABVD versus Stanford V versus MOPP/EBV/CAD in patients with newly diagnosed advanced-stage Hodgkin's lymphoma: a study from the Intergruppo Italiano Linfomi. Chisesi T; Bellei M; Luminari S; Montanini A; Marcheselli L; Levis A; Gobbi P; Vitolo U; Stelitano C; Pavone V; Merli F; Liberati M; Baldini L; Bordonaro R; Pesce EA; Federico M J Clin Oncol; 2011 Nov; 29(32):4227-33. PubMed ID: 21990405 [TBL] [Abstract][Full Text] [Related]
92. Childhood Hodgkin International Prognostic Score (CHIPS) Predicts event-free survival in Hodgkin Lymphoma: A Report from the Children's Oncology Group. Schwartz CL; Chen L; McCarten K; Wolden S; Constine LS; Hutchison RE; de Alarcon PA; Keller FG; Kelly KM; Trippet TA; Voss SD; Friedman DL Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27786406 [TBL] [Abstract][Full Text] [Related]
93. Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin's lymphoma: final analysis of the HD12 trial of the German Hodgkin Study Group. Borchmann P; Haverkamp H; Diehl V; Cerny T; Markova J; Ho AD; Eich HT; Mueller-Hermelink HK; Kanz L; Greil R; Rank A; Paulus U; Smardova L; Huber C; Dörken B; Nerl C; Krause SW; Mueller RP; Fuchs M; Engert A J Clin Oncol; 2011 Nov; 29(32):4234-42. PubMed ID: 21990399 [TBL] [Abstract][Full Text] [Related]
94. Does Interim PET Scan After 2 Cycles of ABVD Predict Outcome in Hodgkin Lymphoma? Real-World Evidence. Seshachalam A; Karpurmath SV; Rathnam K; Raman SG; Janarthinakani M; Prasad K; Patil C; Anoop P; Reddy N; Anumula SK; Roopa SP; Golamari KR; Danthala M; Gunari P; Malipatil B; Rangarajan B; Udupa KS; Nandennavar M; Niraimathi K; Shewade HD J Glob Oncol; 2019 Nov; 5():1-13. PubMed ID: 31834832 [TBL] [Abstract][Full Text] [Related]
95. Radiation for diffuse large B-cell lymphoma in the rituximab era: analysis of the National Comprehensive Cancer Network lymphoma outcomes project. Dabaja BS; Vanderplas AM; Crosby-Thompson AL; Abel GA; Czuczman MS; Friedberg JW; Gordon LI; Kaminski M; Niland J; Millenson M; Nademanee AP; Zelenetz A; LaCasce AS; Rodriguez MA Cancer; 2015 Apr; 121(7):1032-9. PubMed ID: 25492236 [TBL] [Abstract][Full Text] [Related]
96. Fertility in young patients following treatment for Hodgkin's lymphoma: a single center survey. Boltežar L; Pintarić K; Jezeršek Novaković B J Assist Reprod Genet; 2016 Mar; 33(3):325-333. PubMed ID: 26678493 [TBL] [Abstract][Full Text] [Related]
97. Predicted Risks of Cardiovascular Disease Following Chemotherapy and Radiotherapy in the UK NCRI RAPID Trial of Positron Emission Tomography-Directed Therapy for Early-Stage Hodgkin Lymphoma. Cutter DJ; Ramroth J; Diez P; Buckle A; Ntentas G; Popova B; Clifton-Hadley L; Hoskin PJ; Darby SC; Radford J; Illidge T J Clin Oncol; 2021 Nov; 39(32):3591-3601. PubMed ID: 34388007 [TBL] [Abstract][Full Text] [Related]
98. Initial cancer treatment and survival in children, adolescents, and young adults with Hodgkin lymphoma: A population-based study. Kahn JM; Maguire FB; Li Q; Abrahão R; Flerlage JE; Alvarez E; Keegan THM Cancer; 2021 Dec; 127(24):4613-4619. PubMed ID: 34494662 [TBL] [Abstract][Full Text] [Related]
99. Racial disparities in the survival of American children, adolescents, and young adults with acute lymphoblastic leukemia, acute myelogenous leukemia, and Hodgkin lymphoma. Kahn JM; Keegan TH; Tao L; Abrahão R; Bleyer A; Viny AD Cancer; 2016 Sep; 122(17):2723-30. PubMed ID: 27286322 [TBL] [Abstract][Full Text] [Related]
100. Subsequent malignant neoplasms among children with Hodgkin lymphoma: a report from the Children's Oncology Group. Giulino-Roth L; Pei Q; Buxton A; Bush R; Wu Y; Wolden SL; Constine LS; Kelly KM; Schwartz CL; Friedman DL Blood; 2021 Mar; 137(11):1449-1456. PubMed ID: 33512412 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]